Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 6, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Wet AMD can now be tested and treated even before it starts!!!

AIMT Life Science JRF Job | Amity University Noida

FRESHERS Govt Research Interns at HLL | Biotech/ Biochem/ Microbiology Apply

Wet AMD can now be tested and treated even before it starts!!!
  • BiotechToday
  • World

Wet AMD can now be tested and treated even before it starts!!!

bioxone December 27, 2020December 27, 2020

Camelia Bhattacharyya, Amity University Kolkata

It is often said that a person’s confidence is measured through the amount of eye contact it makes. In an interview or even a group discussion or any performance, eye contact is something that drives the attention. But what if a person loses his/her sight? All the beauty of the world, the new research, and developments and also the growth and changes in the civilization would be something he/she would not be able to experience properly. But when it comes to modernization and growth, it is science we speak about, and science as we know finds a solution whatever the problem may be. A research team from the University College London (UCL) has recently shown how to test for wet age-related macular degeneration (wet AMD) which is a major cause leading to vision loss.  

Wet AMD is a disorder that can cause a blind spot due to blood and fluid leakage, in the macula. If this leakage can be easily identified, and at its early stage, then further treatment can help in treating the cause, thus restricting the disease (blindness) from even appearing. The new research focuses on using artificial intelligence (AI) to detect wet AMD 3 years before the arrival of the first symptoms. The Detection of Apoptosing Retinal Cells (DARC) is based on fluorescent tagging where the damaged endothelial cells of the retina region show a specific level of fluorescence. AI is then used to predict the minute difference in the fluorescently tagged cells to predict future disturbances even before they arise. 

This process uses an old technology (DARC), combines it with a new one (AI), and creates a miracle that can act as a scientific boon to patients with a disease that was considered untreatable 2 decades ago.      

Also read: American mink: The first wild animal infected with Coronavirus

Source: https://www.ucl.ac.uk/news/2020/dec/ai-supported-test-predicts-eye-disease-three-years-symptoms

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Related

Tagged AI blindness DARC macula retina solution symptoms UCL untreatable vision loss wet AMD

One thought on “Wet AMD can now be tested and treated even before it starts!!!”

  1. Pingback: Triple-negative breast cancer and PARP inhibitor to overcome immunosuppressive macrophages - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Job and Internship
  • Signaling Pathway

FRESHERS Govt Research Interns at HLL | Biotech/ Biochem/ Microbiology Apply

bioxone December 27, 2020

-Shristi Sharma, Team bioXone Research Interns at HLL – Biotech/ Biochem/ Microbiology Apply. Freshers Research Interns Jobs. MSc Biotechnology/ Biochemistry & Microbiology research interns at HLL. FRESHERS Jobs. Check out all of the details on the same below: Recruitment of Research interns under the Training and Development Scheme of the Company at HLL Corporate R&D […]

Related Post

  • BiotechToday
  • World

Tiny bacteria know how to change to survive inside humans

BioTech Today January 28, 2022January 28, 2022

Debarati Basu, Makaut WB The microorganisms that inhabited our mouths are inclusively known as the oral microbiome. These microorganisms (tiny bacteria, etc.) influence our general wellbeing in numerous ways that are not yet completely comprehended. A few microorganisms cause inflammation, which can lead to periodontitis and other foundational infections, like cardiovascular disease and diabetes. Other […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

Decontamination strategy for detection of cfmDNA in humans

bioxone June 26, 2021June 26, 2021

Madhavi Bhatia, NIPER Guwahati. The gut flora of humans acts as a major factor that influences the health of an individual. The microbiome may affect the disease progression and response to immunotherapy. So, the gut microbiome can act as a cancer biomarker. For analyzing this high throughput 16S-rRNA-gene-based approach is utilized to detect a genuine […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • World

Association of kidney and liver biomarkers with MetS

bioxone July 28, 2021July 27, 2021

Madhavi Bhatia, National Institute of Pharmaceutical Education and Research, Guwahati Metabolic syndrome (MetS) is a group of cardiometabolic conditions that are leading contributors to an elevated risk for cardiovascular disease (CVD) and type II diabetes. Many consequences have been identified which occur due to MetS, an increased risk of fatty liver disease, renal disease, and […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy